Next Article in Journal
Synthesis of 1,2,6-Thiadiazin 1,1-Dioxide Derivatives as Trypanocidal Agents
Previous Article in Journal
Practical and Efficient Procedure for the In Situ Preparation of B-Alkoxyoxazaborolidines. Enantioselective Reduction of Prochiral Ketones
Article Menu

Export Article

Open AccessAbstract
Molecules 2000, 5(3), 497-498; doi:10.3390/50300497

Synthetic Modifications of Lead Compounds as Antitrypanosomal Drugs

1
Cátedra de Química Orgánica, Facultad de Química, Universidad de la República. General Flores 2124, Montevideo, Uruguay
2
Departamento de Fisicoquímica Biológica, Facultad de Ciencias, Universidad de la República. General Flores 2124, Montevideo, Uruguay
3
Departamento de Bioquímica, Facultad de Medicina, Universidad de la República. General Flores 2124, Montevideo, Uruguay
*
Author to whom correspondence should be addressed.
Published: 22 March 2000
View Full-Text   |   Download PDF [14 KB, uploaded 18 June 2014]

Abstract

Following our work in the synthesis of compounds with antichagasic activity, we describe new potential products in which the same "leader" compound was modulated. View Full-Text
This is an open access article distributed under the Creative Commons Attribution License (CC BY 3.0).

Share & Cite This Article

MDPI and ACS Style

Cerecetto, H.; Di Maio, R.; Seoane, G.; Denicola, A.; Peluffo, G.; Quijano, C. Synthetic Modifications of Lead Compounds as Antitrypanosomal Drugs. Molecules 2000, 5, 497-498.

Show more citation formats Show less citations formats

Related Articles

Article Metrics

Article Access Statistics

1

Comments

[Return to top]
Molecules EISSN 1420-3049 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert
Back to Top